DEXCOM INC. DL-,001/ US2521311074 /
20/09/2024 21:38:21 | Diferencia -1.620 | Volumen | Bid22:00:01 | Ask22:00:01 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
62.690EUR | -2.52% | 10 Volumen de negocios: 643.500 |
-Volumen de oferta: - | -Tamaño/ Volumen/ Formato de Ask: - | 25.28 mil millonesEUR | - | - |
Newsfile Corp
4:15
NETA X First Batch Delivered in Hong Kong, Partnering with F1 in Schools Hong Kong, Co-Creating an I...
Newsfile Corp
3:18
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Befo...
Newsfile Corp
2:48
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Moderna, Inc. Investors to Secure Counsel Before Importan...
Newsfile Corp
2:11
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Allarity Therapeutics, Inc. Investors to Secur...
Newsfile Corp
1:30
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sprinklr, Inc. Investors to Secure Counsel Before Import...
Newsfile Corp
1:11
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Coinbase Global, Inc. Investors to Secure Counsel Bef...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página